Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash flows from operating activities:
Net income	$ 207,187	$ 271,513	$ 187,551
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	28,396	29,097	3,500
Equity in (income) loss of unconsolidated entities, net	(9,264)	(8,124)	5,007
Deferred income taxes, net	17,864	11,074	46,810
Amortization of stock-based compensation	14,806	14,814	15,906
Charges for impairments and lot option abandonments	24,875	5,085	2,053
Changes in assets and liabilities:
Real estate inventories	120,272	(91,757)	(205,229)
Receivables	(17,684)	74,545	(44,280)
Other assets	(12,369)	(9,895)	13,487
Accounts payable	(15,193)	3,222	2,618
Accrued expenses and other liabilities	(52,118)	1,906	67,036
Returns on investments in unconsolidated entities, net	9,208	9,182	7,215
Net cash provided by operating activities	315,980	310,662	101,674
Cash flows from investing activities:
Purchases of property and equipment	(30,282)	(31,651)	(2,605)
Proceeds from sale of property and equipment	46	8	6
Investments in unconsolidated entities	(7,022)	(2,274)	(980)
Net cash paid for acquisition	0	(61,495)	0
Net cash used in investing activities	(37,258)	(95,412)	(3,579)
Cash flows from financing activities:
Borrowings from debt	400,000	125,000	500,000
Repayment of debt	(531,895)	(193,105)	(413,726)
Debt issuance costs	(3,125)	0	(5,957)
Distributions to noncontrolling interests	0	(2,194)	(1,333)
Proceeds from issuance of common stock under share-based awards	449	1,943	12,291
Minimum tax withholding paid on behalf of employees for share-based awards	(3,612)	(6,049)	(2,896)
Share repurchases	(89,224)	(146,063)	(112,217)
Net cash used in financing activities	(227,407)	(220,468)	(23,838)
Net increase (decrease) in cash and cash equivalents	51,315	(5,218)	74,257
Cash and cash equivalents - beginning of year	277,696	282,914	208,657
Cash and cash equivalents - end of year	$ 329,011	$ 277,696	$ 282,914